Clinical trial
Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines
NCT00443131 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00443131 |
|---|---|
| Title | Characterisation of the Immune Responses of 2 Experimental Malaria Vaccines |
| Official title | Adjuvant Justification Study of Candidate Malaria Vaccines (257049), Administered According to a 0, 1, 2 Months Schedule . |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Biological |
| Interventions | GSK Malaria vaccine 257049 |
| Enrollment | 36 |
| Start date | Mar 26, 2007 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 13, 2007 |
| First posted | Mar 5, 2007 |
| Last update posted | Apr 25, 2017 |
| Countries | Belgium |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: